Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nexgel (NXGL) EBT Margin (2018 - 2025)

Nexgel (NXGL) has disclosed EBT Margin for 8 consecutive years, with 22.04% as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, EBT Margin rose 359.0% year-over-year to 22.04%, compared with a TTM value of 23.92% through Sep 2025, up 3293.0%, and an annual FY2024 reading of 39.86%, up 3811.0% over the prior year.
  • EBT Margin was 22.04% for Q3 2025 at Nexgel, up from 22.19% in the prior quarter.
  • Across five years, EBT Margin topped out at 22.04% in Q3 2025 and bottomed at 463.64% in Q1 2022.
  • Average EBT Margin over 5 years is 143.31%, with a median of 109.7% recorded in 2023.
  • The sharpest move saw EBT Margin soared 38434bps in 2021, then plummeted -19997bps in 2022.
  • Year by year, EBT Margin stood at 331.77% in 2021, then surged by 63bps to 123.66% in 2022, then increased by 11bps to 109.7% in 2023, then soared by 75bps to 27.13% in 2024, then increased by 19bps to 22.04% in 2025.
  • Business Quant data shows EBT Margin for NXGL at 22.04% in Q3 2025, 22.19% in Q2 2025, and 24.16% in Q1 2025.